Yannick Cerantola

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


49 publications

2024 | 2022 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
 
Impact of Enhanced Recovery after Surgery<sup>®</sup> Protocol Compliance on Length of Stay, Bowel Recovery and Complications after Radical Cystectomy.
Grilo N., Crettenand F., Bohner P., Rodrigues Dias S.C., Cerantola Y., Lucca I., 2024/01/25. Diagnostics, 14 (3). Peer-reviewed.
ERAS® protocol improves survival after radical cystectomy: A single-center cohort study.
Crettenand F., M'Baya O., Grilo N., Valerio M., Dartiguenave F., Cerantola Y., Roth B., Rouvé J.D., Blanc C., Lucca I., 2022/09/02. Medicine, 101 (35) pp. e30258. Peer-reviewed.
 
Reporting Radical Cystectomy Outcomes Following Implementation of Enhanced Recovery After Surgery Protocols: A Systematic Review and Individual Patient Data Meta-analysis.
Williams S.B., Cumberbatch MGK, Kamat A.M., Jubber I., Kerr P.S., McGrath J.S., Djaladat H., Collins J.W., Packiam V.T., Steinberg G.D. et al., 2020/11. European urology, 78 (5) pp. 719-730. Peer-reviewed.
 
Intramuscular Immunization Induces Antigen-specific Antibodies in Urine.
Derré L., Lucca I., Cesson V., Valerio M., Cerantola Y., Burruni R., Fritschi U., Gharbi D., Bobst M., Legris A.S. et al., 2020/03/15. European urology focus, 6 (2) pp. 280-283. Peer-reviewed.
 
Version courte des recommandations de la récupération ameliorée après chirurgie (RAAC) pour la cystectomie : mesures techniques [Short version of recommendations for enhanced recovery program (ERP) for cystectomy: Technical measures]
Poinas G., Blache J.L., Kassab-Chahmi D., Evrard P.L., Artus P.M., Alfonsi P., Rébillard X., Beaussier M., Cerantola Y., Coloby P. et al., 2019/02. Progres en urologie, 29 (2) pp. 63-75. Peer-reviewed.
 
Réhabilitation améliorée après chirurgie urologique majeure : quel rôle pour le médecin généraliste ? [Improved rehabilitation after major urological surgery : what role for the general practitioner ?]
Martel P., Crettenand F., M'baya O., Cerantola Y., Jichlinski P., Lucca I., 2018/11/28. Revue medicale suisse, 14 (629) pp. 2150-2153. Peer-reviewed.
 
L’application d’un programme de réhabilitation précoce (ERAS) améliore-t-elle les résultats périopératoires après cystectomie ? [Do initial experience with an enhanced recovery program after surgery (ERAS) improve postoperative outcomes after cystectomy?]
Baldini A., Fassi Fehri H., Cerantola Y., Bayle F., Ravier E., Belot P.Y., Arnouil N., Colombel M., Badet L., 2018/05. Progres en urologie, 28 (6) pp. 351-358. Peer-reviewed.
 
Ablation du cancer primaire dans les néoplasies urologiques oligométastatiques : évidence ou vœux pieux ? [Local treatment in oligometastatic urological malignancies : evidence of wishful thinking ?]
Valerio M., Cerantola Y., Lucca I., Berthold D., Jichlinski P., 2017/11/29. Revue medicale suisse, 13 (585) pp. 2083-2086. Peer-reviewed.
 
Immunonutrition en uro-oncologie : entre mythe et réalité [Myths and reality about immunonutrition in uro-oncology]
Cerantola Y., 2017/11/29. Revue medicale suisse, 13 (585) pp. 2079-2082. Peer-reviewed.
 
Inguinal Bladder Hernia With Acute Ureteral Obstruction 14 Years After Kidney Transplantation: A Case Report.
Ghielmini E., Julita L., Cerantola Y., Matter M., Zingg T., 2017/09. Transplantation proceedings, 49 (7) pp. 1593-1595. Peer-reviewed.
 
Does teaching of robotic partial nephrectomy affect renal function and perioperative outcomes?
Cerantola Y., Ploussard G., Kassouf W., Anidjar M., Bladou F., 2017/05. Urologic oncology, 35 (5) pp. 227-233. Peer-reviewed.
 
Intravesical Bacillus Calmette Guerin Combined with a Cancer Vaccine Increases Local T-Cell Responses in Non-muscle-Invasive Bladder Cancer Patients.
Derré L., Cesson V., Lucca I., Cerantola Y., Valerio M., Fritschi U., Vlamopoulos Y., Burruni R., Legris A.S., Dartiguenave F. et al., 2017/02/01. Clinical cancer research, 23 (3) pp. 717-725. Peer-reviewed.
 
Initial single-centre Canadian experience with 18F-fluoromethylcholine positron emission tomography-computed tomography (18F-FCH PET/CT) for biochemical recurrence in prostate cancer patients initially treated with curative intent.
Gauvin S., Cerantola Y., Haberer E., Pelsser V., Probst S., Bladou F., Anidjar M., 2017. Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 11 (1-2) pp. 47-52. Peer-reviewed.
 
New and Established Technology in Focal Ablation of the Prostate: A Systematic Review.
Valerio M., Cerantola Y., Eggener S.E., Lepor H., Polascik T.J., Villers A., Emberton M., 2017/01. European urology, 71 (1) pp. 17-34. Peer-reviewed.
 
Bilan et traitements des infections urogénitales [Assessment and treatment of genitourinary infections]
Martel P., M'Baya O., Senn L., Jichlinski P., Cerantola Y., 2016/11/30. Revue medicale suisse, 12 (541) pp. 2054-2059. Peer-reviewed.
 
The role of minimally invasive surgery on enhanced recovery after nephrectomy
M'Baya Olivier, Grilo Nuno, Valerio Massimo, Dartiguenave Florence, Puricel Serban, Blanc Catherine, Jichlinski Patrice, Cerantola Yannick, 2016/04. pp. e52 dans Clinical Nutrition ESPEN.
 
Accuracy of cognitive MRI-targeted biopsy in hitting prostate cancer-positive regions of interest.
Cerantola Y., Haberer E., Torres J., Alameldin M., Aronson S., Levental M., Bladou F., Anidjar M., 2016/01. World journal of urology, 34 (1) pp. 75-82. Peer-reviewed.
 
Cost-effectiveness of multiparametric magnetic resonance imaging and targeted biopsy in diagnosing prostate cancer.
Cerantola Y., Dragomir A., Tanguay S., Bladou F., Aprikian A., Kassouf W., 2016. Urologic Oncology, 34 (3) pp. 119.e1-119.e9. Peer-reviewed.
 
The role of renal biopsy in small renal masses.
Burruni R., Lhermitte B., Cerantola Y., Tawadros T., Meuwly J.Y., Berthold D., Jichlinski P., Valerio M., 2016. Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 10 (1-2) pp. E28-33. Peer-reviewed.
 
Incontinence urinaire chez la femme âgée: que faire au cabinet? [Urinary incontinence in older women: what can a GP do?]
Ernst V., Saïah L., Cerantola Y., Bosshard Taroni W., Haftgoli N., Büla C., 2015/11/11. Revue medicale suisse, 11 (494) pp. 2104,2106-2109. Peer-reviewed.
 
Biopsies de la prostate en 2015: quelle biopsie pour quel patient [Prostate biopsy: which strategy for which patient?].
Burruni R., Cerantola Y., Meuwly J.Y., Tawadros T., Jichlinski P., Valerio M., 2015. Revue Médicale Suisse, 11 (497) pp. 2288-90, 2292.
 
Compliance with preoperative oral nutritional supplements in patients at nutritional risk─only a question of will?
Grass F., Bertrand P.C., Schäfer M., Ballabeni P., Cerantola Y., Demartines N., Hübner M., 2015. European Journal of Clinical Nutrition, 69 (4) pp. 525-529. Peer-reviewed.
 
Inégalité des sexes face au cancer en urologie [Gender disparities in urologic cancers].
Lucca I., Valerio M., Jichlinski P., Cerantola Y., 2015. Revue Médicale Suisse, 11 (497) pp. 2276-8, 2280.
Preoperative nutritional screening by the specialist instead of the nutritional risk score might prevent excess nutrition: a multivariate analysis of nutritional risk factors.
Grass F., Hübner M., Schäfer M., Ballabeni P., Cerantola Y., Demartines N., Pralong F.P., Bertrand P.C., 2015. Nutrition Journal, 14 (1) p. 37. Peer-reviewed.
 
Urologie [Urology].
Boldini M., Cerantola Y., Jichlinski P., Valerio M., 2015. Revue Médicale Suisse, 11 (456-457) pp. 143-147.
 
Comorbidity and nutritional indices as predictors of morbidity after transurethral procedures: A prospective cohort study.
Valerio M., Cerantola Y., Fritschi U., Hubner M., Iglesias K., Legris A.S., Lucca I., Vlamopoulos Y., Vaucher L., Jichlinski P., 2014. Canadian Urological Association Journal, 8 (9-10) pp. E600-E604. Peer-reviewed.
 
Cost-effectiveness analysis of immune-modulating nutritional support for gastrointestinal cancer patients.
Chevrou-Séverac H., Pinget C., Cerantola Y., Demartines N., Wasserfallen J.B., Schäfer M., 2014. Clinical Nutrition, 33 (4) pp. 649-654. Peer-reviewed.
 
Enhanced recovery after surgery: are we ready, and can we afford not to implement these pathways for patients undergoing radical cystectomy?
Patel H.R., Cerantola Y., Valerio M., Persson B., Jichlinski P., Ljungqvist O., Hubner M., Kassouf W., Müller S., Baldini G. et al., 2014. European Urology, 65 (2) pp. 263-266. Peer-reviewed.
 
Thérapie focale du cancer de la prostate: rationnel, résultats et perspectives [Focal therapy in prostate cancer: rationale, results and perspectives].
Valerio M., Benamran D., Tawadros T., Cerantola Y., Meuwly J.Y., Lutchmaya-Flick C., Lhermitte B., Wirth G., Iselin C., Jichlinski P., 2014. Revue Médicale Suisse, 10 (453) pp. 2306-2310. Peer-reviewed.
 
Are patients at nutritional risk more prone to complications after major urological surgery?
Cerantola Y., Valerio M., Hubner M., Iglesias K., Vaucher L., Jichlinski P., 2013. Journal of Urology, 190 (6) pp. 2126-2132. Peer-reviewed.
 
Can 3T multiparametric magnetic resonance imaging accurately detect prostate cancer extracapsular extension?
Cerantola Y., Valerio M., Kawkabani Marchini A., Meuwly J.Y., Jichlinski P., 2013. Canadian Urological Association Journal = Journal De L'association Des Urologues Du Canada, 7 (11-12) pp. E699-E703. Peer-reviewed.
 
Guidelines for perioperative care after radical cystectomy for bladder cancer: enhanced Recovery After Surgery (ERAS(®)) society recommendations.
Cerantola Y., Valerio M., Persson B., Jichlinski P., Ljungqvist O., Hubner M., Kassouf W., Muller S., Baldini G., Carli F. et al., 2013. Clinical Nutrition, 32 (6) pp. 879-887. Peer-reviewed.
Rétablissement postopératoire optimisé, applique aux patients après cystectomie [Enhanced recovery after surgery applied to cystectomy patients].
M'Baya O., Vlamopoulos Y., Hubner M., Blanc C., Jichlinski P., Cerantola Y., 2013. Revue Médicale Suisse, 9 (409) pp. 2279-82, 2284-5. Peer-reviewed.
Preoperative immunonutrition in patients at nutritional risk: results of a double-blinded randomized clinical trial.
Hübner M., Cerantola Y., Grass F., Bertrand P.C., Schäfer M., Demartines N., 2012. European Journal of Clinical Nutrition, 66 (7) pp. 850-855. Peer-reviewed.
 
Contrôle de qualité en urologie [Quality assessment in urology].
Cerantola Y., Jichlinski P., 2011. Revue Médicale Suisse, 7 (320) pp. 2382-2387.
 
Ex vivo ultrasound control of resection margins during partial nephrectomy.
Doerfler A., Cerantola Y., Meuwly J.Y., Lhermitte B., Bensadoun H., Jichlinski P., 2011. Journal of Urology, 186 (6) pp. 2188-2193.
 
Ex-Vivo Ultransonographic Control Of Resection Margin During Partial Nephrectomy
Cerantola Y., Chollet Y., Meuwly J.Y., Jichlinski P., Doerfler A., 2011. pp. 55-56 dans 26th Annual Congress of the European Association of Urology, European Urology Supplements. Peer-reviewed.
 
Ex-vivo ultrasound control of resection margins during partial nephrectomy
Cerantola Y., Doerfler A., Chollet Y., Meuwly J.Y., Jichlinsky P., 2011. pp. S21 dans European School of Oncology Educational Cancer Lugano Convention (ECCLU), Workshop on Whats New and Whats True in Genito-Urinary Oncology, Critical Reviews in Oncology Hematology. Peer-reviewed.
Immunonutrition in gastrointestinal surgery.
Cerantola Y., Hübner M., Grass F., Demartines N., Schäfer M., 2011. British Journal of Surgery, 98 (1) pp. 37-48. Peer-reviewed.
Perioperative nutrition in abdominal surgery: recommendations and reality.
Cerantola Y., Grass F., Cristaudi A., Demartines N., Schäfer M., Hübner M., 2011. Gastroenterology Research and Practice, 2011 p. 739347. Peer-reviewed.
Perioperative nutrition is still a surgical orphan: results of a Swiss-Austrian survey.
Grass F., Cerantola Y., Schäfer M., Müller S., Demartines N., Hübner M., 2011. European Journal of Clinical Nutrition, 65 (5) pp. 642-647. Peer-reviewed.
 
Surveillance active du cancer de la prostate [Active surveillance in prostate cancer].
Valerio M., Vaucher L., Cerantola Y., Berthold D., Herrera F.G, Jichlinski P., 2011. Revue Médicale Suisse, 7 (320) pp. 2388-2391. Peer-reviewed.
 
Systematic review of delayed postoperative hemorrhage after pancreatic resection
Roulin D., Cerantola Y., Demartines N., Schaefer M., 2011. p. 10 dans 98th Annual Congress of the Swiss Society of Surgery, British Journal of Surgery. Peer-reviewed.
Systematic review of delayed postoperative hemorrhage after pancreatic resection.
Roulin D., Cerantola Y., Demartines N., Schäfer M., 2011. Journal of Gastrointestinal Surgery, 15 (6) pp. 1055-1062.
 
Electrical colonic stimulation reduces mean transit time in a porcine model.
Vaucher J., Cerantola Y., Gie O., Letovanec I., Virag N., Demartines N., Gardaz J.P., Givel J.C., 2010. Neurogastroenterology and motility, 22 pp. 88-92, e31.
Perioperative nutrition is still a surgical orphan
Grass F., Huebner M., Cerantola Y., Muller S., Schaefer M., Demartines N., 2010. p. 6 dans 97th Annual Congress of the Swiss Society of Surgery, British Journal of Surgery. Peer-reviewed.
 
Rapamycin-mediated FOXO1 inactivation reduces the anticancer efficacy of rapamycin.
Abdelnour-Berchtold E., Cerantola Y., Roulin D., Dormond-Meuwly A., Demartines N., Dormond O., 2010. Anticancer Research, 30 (3) pp. 799-804.
Targeting mTORC2 inhibits colon cancer cell proliferation in vitro and tumor formation in vivo.
Roulin D., Cerantola Y., Dormond-Meuwly A., Demartines N., Dormond O., 2010. Molecular Cancer, 9 p. 57. Peer-reviewed.
 
Prise en charge actuelle de l'incontinence anale [Current management of anal incontinence]
Cerantola Y., Aellen S., Givel J.C., 2009. Revue Médicale Suisse, 5 (209) pp. 1421-1424.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University